Page last updated: 2024-11-12

6-nitrodopamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-nitrodopamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10932412
CHEMBL ID40212
CHEBI ID125478
SCHEMBL ID1278365
MeSH IDM0357044

Synonyms (16)

Synonym
CHEBI:125478
CHEMBL40212
1,2-benzenediol, 4-(2-aminoethyl)-5-nitro-
21581-49-7
BRD-K08227907-001-01-8
GAWRYVJRKWPEFX-UHFFFAOYSA-N
6-nitro dopamine
SCHEMBL1278365
6-nitrodopamine
Q27216097
4-(2-aminoethyl)-5-nitrobenzene-1,2-diol
DTXSID20448788
AKOS030255118
CS-0438602
4-(2-aminoethyl)-5-nitro-1,2-benzenediol
E80503
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
catecholamine4-(2-Aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID147259Effect on the activity of recombinant rat neuronal nitric oxide synthase as determined with radioactive L-arginine/L-citruline conversion assay2002Bioorganic & medicinal chemistry letters, Jan-07, Volume: 12, Issue:1
Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's2 (13.33)24.3611
2020's9 (60.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.79 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.53 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]